Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$1.43 - $3.14 $1.91 Million - $4.19 Million
-1,333,278 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$2.7 - $4.76 $1.67 Million - $2.94 Million
618,590 Added 86.55%
1,333,278 $3.61 Million
Q3 2021

Nov 10, 2021

BUY
$4.06 - $5.8 $1.07 Million - $1.53 Million
263,392 Added 58.36%
714,688 $3.19 Million
Q2 2021

Aug 10, 2021

SELL
$5.02 - $7.05 $550,332 - $772,877
-109,628 Reduced 19.54%
451,296 $2.62 Million
Q1 2021

May 10, 2021

BUY
$4.81 - $10.34 $1.77 Million - $3.81 Million
368,716 Added 191.83%
560,924 $3.94 Million
Q4 2020

Feb 10, 2021

SELL
$4.13 - $6.41 $562,898 - $873,650
-136,295 Reduced 41.49%
192,208 $923,000
Q3 2020

Nov 13, 2020

BUY
$4.82 - $7.72 $902,434 - $1.45 Million
187,227 Added 132.53%
328,503 $1.92 Million
Q2 2020

Aug 07, 2020

BUY
$5.69 - $9.69 $708,012 - $1.21 Million
124,431 Added 738.68%
141,276 $954,000
Q1 2020

May 15, 2020

SELL
$3.77 - $11.0 $476,019 - $1.39 Million
-126,265 Reduced 88.23%
16,845 $107,000
Q4 2019

Feb 10, 2020

BUY
$3.0 - $16.43 $429,330 - $2.35 Million
143,110 New
143,110 $1.49 Million
Q3 2019

Nov 14, 2019

SELL
$3.93 - $15.35 $1.44 Million - $5.63 Million
-367,079 Closed
0 $0
Q2 2019

Aug 09, 2019

BUY
$12.81 - $25.67 $2.39 Million - $4.79 Million
186,542 Added 103.33%
367,079 $5.46 Million
Q1 2019

May 15, 2019

BUY
$17.66 - $30.28 $3.19 Million - $5.47 Million
180,537 New
180,537 $4.48 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.